|
1
|
Vermeulen L, Sprick MR, Kemper K, Stassi G
and Medema JP: Cancer stem cells - old concepts, new insights. Cell
Death Differ. 15:947–958. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gupta PB, Chaffer CL and Weinberg RA:
Cancer stem cells: mirage or reality? Nat Med. 15:1010–1012. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
O’Brien CA, Kreso A and Dick JE: Cancer
stem cells in solid tumors: an overview. Semin Radiat Oncol.
19:71–77. 2009.
|
|
4
|
Lonardo E, Hermann PC, Mueller MT, et al:
Nodal/Activin signaling drives self-renewal and tumorigenicity of
pancreatic cancer stem cells and provides a target for combined
drug therapy. Cell Stem Cell. 9:433–446. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Anderson EC, Hessman C, Levin TG, Monroe
MM and Wong MH: The role of colorectal cancer stem cells in
metastatic disease and therapeutic response. Cancers. 3:319–339.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Horst D, Kriegl L, Engel J, Kirchner T and
Jung A: Prognostic significance of the cancer stem cell markers
CD133, CD44, and CD166 in colorectal cancer. Cancer Invest.
27:844–850. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Thorne RF, Legg JW and Isacke CM: The role
of the CD44 transmembrane and cytoplasmic domains in co-ordinating
adhesive and signalling events. J Cell Sci. 117:373–380. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ofori-Acquah SF and King JA: Activated
leukocyte cell adhesion molecule: a new paradox in cancer. Transl
Res. 151:122–128. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
van Kempen LC, van den Oord JJ, van Muijen
GN, Weidle UH, Bloemers HP and Swart GW: Activated leukocyte cell
adhesion molecule/CD166, a marker of tumor progression in primary
malignant melanoma of the skin. Am J Pathol. 156:769–774.
2000.PubMed/NCBI
|
|
10
|
King JA, Ofori-Acquah SF, Stevens T,
Al-Mehdi AB, Fodstad O and Jiang WG: Activated leukocyte cell
adhesion molecule in breast cancer: prognostic indicator. Breast
Cancer Res. 6:R478–R487. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Burkhardt M, Mayordomo E, Winzer KJ, et
al: Cytoplasmic overexpression of ALCAM is prognostic of disease
progression in breast cancer. J Clin Pathol. 59:403–409. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Weichert W, Knösel T, Bellach J, Dietel M
and Kristiansen G: ALCAM/CD166 is overexpressed in colorectal
carcinoma and correlates with shortened patient survival. J Clin
Pathol. 57:1160–1164. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tachezy M, Zander H, Gebauer F, et al:
Activated leukocyte cell adhesion molecule (CD166) - its prognostic
power for colorectal cancer patients. J Surg Res. 177:e15–e20.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Levin TG, Powell AE, Davies PS, et al:
Characterization of the intestinal cancer stem cell marker CD166 in
the human and mouse gastrointestinal tract. Gastroenterology.
139:2072–2082. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
van Kilsdonk JW, Wilting RH, Bergers M, et
al: Attenuation of melanoma invasion by a secreted variant of
activated leukocyte cell adhesion molecule. Cancer Res.
68:3671–3679. 2008.PubMed/NCBI
|
|
16
|
Campbell VW, Davin D, Thomas S, et al: The
G-C specific DNA binding drug, mithramycin, selectively inhibits
transcription of the C-MYC and C-HA-RAS genes in regenerating
liver. Am J Med Sci. 307:167–172. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Guo Z, Zhang W, Xia G, et al: Sp1
upregulates the four and half lim 2 (FHL2) expression in
gastrointestinal cancers through transcription regulation. Mol
Carcinog. 49:826–836. 2010.PubMed/NCBI
|
|
18
|
Tian H, Qian GW, Li W, et al: A critical
role of Sp1 transcription factor in regulating the human Ki-67 gene
expression. Tumour Biol. 32:273–283. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jungert K, Buck A, von Wichert G, et al:
Sp1 is required for transforming growth factor-β-induced
mesenchymal transition and migration in pancreatic cancer cells.
Cancer Res. 67:1563–1570. 2007.
|
|
20
|
Leung EL, Fiscus RR, Tung JW, et al:
Non-small cell lung cancer cells expressing CD44 are enriched for
stem cell-like properties. PLoS One. 5:e140622010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sperling C, Schwartz S, Buchner T, Thiel E
and Ludwig WD: Expression of the stem cell factor receptor C-KIT
(CD117) in acute leukemias. Haematologica. 82:617–621.
1997.PubMed/NCBI
|
|
22
|
Lee J, Kotliarova S, Kotliarov Y, et al:
Tumor stem cells derived from glioblastomas cultured in bFGF and
EGF more closely mirror the phenotype and genotype of primary
tumors than do serum-cultured cell lines. Cancer Cell. 9:391–403.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu S, Dontu G, Mantle ID, et al: Hedgehog
signaling and Bmi-1 regulate self-renewal of normal and malignant
human mammary stem cells. Cancer Res. 66:6063–6071. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dey D, Saxena M, Paranjape AN, et al:
Phenotypic and functional characterization of human mammary
stem/progenitor cells in long term culture. PLoS One. 4:e53292009.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tomuleasa C, Soritau O, Rus-Ciuca D, et
al: Isolation and characterization of hepatic cancer cells with
stem-like properties from hepatocellular carcinoma. J
Gastrointestin Liver Dis. 19:61–67. 2010.PubMed/NCBI
|
|
26
|
Sigurdsson V, Hilmarsdottir B,
Sigmundsdottir H, et al: Endothelial induced EMT in breast
epithelial cells with stem cell properties. PLoS One. 6:e238332011.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tellez CS, Juri DE, Do K, et al: EMT and
stem cell-like properties associated with miR-205 and miR-200
epigenetic silencing are early manifestations during
carcinogen-induced transformation of human lung epithelial cells.
Cancer Res. 71:3087–3097. 2011. View Article : Google Scholar
|
|
28
|
Singh A and Settleman J: EMT, cancer stem
cells and drug resistance: an emerging axis of evil in the war on
cancer. Oncogene. 29:4741–4751. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tang Y, Liang X, Zheng M, et al:
Expression of c-kit and Slug correlates with invasion and
metastasis of salivary adenoid cystic carcinoma. Oral Oncol.
46:311–316. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Maeda K, Nishiyama C, Ogawa H and Okumura
K: GATA2 and Sp1 positively regulate the c-kit promoter in mast
cells. J Immunol. 185:4252–4260. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lecuyer E, Herblot S, Saint-Denis M, et
al: The SCL complex regulates c-kit expression in hematopoietic
cells through functional interaction with Sp1. Blood.
100:2430–2440. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chen YC, Hsu HS, Chen YW, et al: Oct-4
expression maintained cancer stem-like properties in lung
cancer-derived CD133-positive cells. PLoS One. 3:e26372008.
View Article : Google Scholar : PubMed/NCBI
|
